I agree that this site is using cookies. You can find further informations here.
X
Suri, Ajit
69  results:
Search for persons X
?
1

Niraparib in Japanese patients with platinum-sensitive recu..:

Itamochi, Hiroaki ; Takeshima, Nobuhiro ; Hamanishi, Junzo...
Journal of Gynecologic Oncology.  35 (2024)  - p. , 2024
Link: https://doi.org/10.3802/..
 
?
2

Su497 PHARMACOKINETICS (PK), SAFETY, AND EFFICACY OF INTRAV..:

Hyams, Jeffrey S. ; Turner, Dan ; Cohen, Stanley A....
Gastroenterology.  160 (2021)  6 - p. S-716 , 2021
Link: https://doi.org/10.1016/..
 
?
3

Phase 2 single-arm study on the efficacy and safety of nira..:

Okamoto, Aikou ; Kondo, Eiji ; Nakamura, Toshiaki...
Journal of Gynecologic Oncology.  32 (2021)  2 - p. , 2021
Link: https://doi.org/10.3802/..
 
?
4

Risk‐Based Pharmacokinetic and Drug–Drug Interaction Charac..:

Li, Chunze ; Menon, Rajeev ; Walles, Markus...
Clinical Pharmacology & Therapeutics.  112 (2021)  4 - p. 754-769 , 2021
Link: https://doi.org/10.1002/..
 
?
5

Phase 2 single-arm study on the safety of maintenance nirap..:

Takehara, Kazuhiro ; Matsumoto, Takashi ; Hamanishi, Junzo...
Journal of Gynecologic Oncology.  32 (2021)  2 - p. , 2021
Link: https://doi.org/10.3802/..
 
?
6

The safety, tolerability and pharmacokinetics of niraparib ..:

Yonemori, Kan ; Shimizu, Toshio ; Kondo, Shunsuke...
Japanese Journal of Clinical Oncology.  51 (2021)  5 - p. 693-699 , 2021
Link: https://doi.org/10.1093/..
 
?
7

Assessment of Vedolizumab Disease‐Drug‐Drug Interaction Pot..:

Sun, Wan ; Lirio, Richard A. ; Schneider, Jennifer...
Clinical Pharmacology in Drug Development.  10 (2020)  7 - p. 734-747 , 2020
Link: https://doi.org/10.1002/..
 
?
8

Population Pharmacokinetics of Brentuximab Vedotin in Adult..:

Suri, Ajit ; Mould, Diane R. ; Song, Gregory..
The Journal of Clinical Pharmacology.  60 (2020)  12 - p. 1585-1597 , 2020
Link: https://doi.org/10.1002/..
 
?
9

Population Pharmacokinetic Modeling and Exposure–Response A..:

Suri, Ajit ; Mould, Diane R. ; Song, Gregory...
Clinical Pharmacology & Therapeutics.  106 (2019)  6 - p. 1268-1279 , 2019
Link: https://doi.org/10.1002/..
 
?
10

Challenges and Opportunities in Dose Finding in Oncology an..:

Ji, Yan ; Jin, Jin Y. ; Hyman, David M...
Clinical and Translational Science.  11 (2018)  4 - p. 345-351 , 2018
Link: https://doi.org/10.1111/..
 
?
11

Population PK and Exposure–Response Relationships for the A..:

Suri, Ajit ; Mould, Diane R. ; Liu, Yi..
Clinical Pharmacology & Therapeutics.  104 (2018)  5 - p. 989-999 , 2018
Link: https://doi.org/10.1002/..
 
?
12

A Phase 1, Randomized, Single‐Dose Crossover Pharmacokineti..:

Suri, Ajit ; Pham, Theresa ; MacLean, David B.
Clinical Pharmacology in Drug Development.  5 (2016)  3 - p. 188-195 , 2016
Link: https://doi.org/10.1002/..
 
?
13

Absorption, Distribution, and Excretion of the Investigatio..:

Suri, Ajit ; Pusalkar, Sandeepraj ; Li, Yuexian.
Clinical Pharmacology in Drug Development.  5 (2016)  3 - p. 180-187 , 2016
Link: https://doi.org/10.1002/..
 
?
14

Phase 1/2 study of orteronel (TAK-700), an investigational ..:

Petrylak, Daniel P. ; Gandhi, Jitendra G. ; Clark, William R....
Investigational New Drugs.  33 (2015)  2 - p. 397-408 , 2015
Link: https://doi.org/10.1007/..
 
?
15

Assessment of cytochrome P450‐mediated drug–drug interactio..:

Lu, Chuang ; Suri, Ajit ; Shyu, Wen Chyi.
Biopharmaceutics & Drug Disposition.  35 (2014)  9 - p. 543-552 , 2014
Link: https://doi.org/10.1002/..
 
1-15